Elizabeth E. Reed - May 10, 2022 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
SVP, GC & Corporate Secretary
Signature
/s/ Elizabeth E. Reed
Stock symbol
TVTX
Transactions as of
May 10, 2022
Transactions value $
-$41,943
Form type
4
Date filed
5/12/2022, 08:47 PM
Previous filing
Feb 2, 2022
Next filing
Jan 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale -$19.4K -900 -2.06% $21.51 42.9K May 10, 2022 Direct F1
transaction TVTX Common Stock Sale -$22.6K -1.05K -2.45% $21.51 41.8K May 12, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.